Loading…
Accurate Reporting of Smoking Variants Act of 2021
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
43pct
1d open
vs 9,698 other HR bills in the 117th — cohort avg 63d
Accurate Reporting of Smoking Variants Act of 2021 This bill requires the Office of the National Coordinator for Health Information Technology to include, in the Federal Health IT Strategic Plan, relevant strategies to capture in electronic health records an individual's use of electronic cigarettes, vaping devices, or other smoking variants in the same manner as the use of traditional tobacco products is captured in such records. Currently, the collection of information about a patient's smoking status with respect to cigarettes or other traditional tobacco products is one of the measures used to determine meaningful use of electronic health records by health care providers.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
Risk-proportionate regulation for electronic nicotine delivery system products to advance tobacco harm reduction for adult smokers and policies to combat underage use; issues related to enforcement of illicit tobacco products, including importation of counterfeit products; and unregulated nicotine products; issues related to taxation and user fees for tobacco and electronic nicotine delivery system products; issues related to regulation of synthetic nicotine products; discussions related to implementation of Public Law 111-31, the Family Smoking Prevention and Tobacco Control Act, and PMTA submissions for deemed tobacco products; H.R. 2125/H.r. 2185/S. 2622, the Quit Because of COVID-19 Act; H.R. 2786/S.1314, the Tobacco Tax Equity Act of 2021; H.R. 3051, the End ENDS Act of 2021; H.R. 3226, the Accurate Reporting of Smoking Variants Act of 2021; H.R. 3407/S.411, the Mothers and Offspring Mortality and Morbidity Awareness Act; H.R. 4629/S. 2445, the Resources to Prevent Youth Vaping Act; H.R. 5546/S. 2974, the PROTECT Act
Referred to the Subcommittee on Health.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Risk-proporitionate regulation for electronic nicotine delivery system products to advance tobacco harm reduction for adult smokers and policies to combat underage use; issues related to enforcement of illicit tobacco products, including importation of counterfeit products; and unregulated nicotine products; issues related to taxation and user fees for tobacco and electronic nicotine delivery system products; issues related to regulation of synthetic nicotine products; discussions related to implementation of Public Law 111-31, the Family Smoking Prevention and Tobacco Control Act, and PMTA submissions for deemed tobacco products; H.R. 2125/H.r. 2185/S. 2622, the Quit Because of COVID-19 Act; H.R. 2786/S.1314, the Tobacco Tax Equity Act of 2021; H.R. 3051, the End ENDS Act of 2021; H.R. 3226, the Accurate Reporting of Smoking Variants Act of 2021; H.R. 3407/S.411, the Mothers and Offspring Mortality and Morbidity Awareness Act; H.R. 4629/S. 2445, the Resources to Prevent Youth Vaping Act; H.R. 5546/S. 2974, the PROTECT Act
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Risk-proporitionate regulation for electronic nicotine delivery system products to advance tobacco harm reduction for adult smokers and policies to combat underage use; issues related to enforcement of illicit tobacco products, including importation of counterfeit products; and unregulated nicotine products; issues related to taxation and user fees for tobacco and electronic nicotine delivery system products; issues related to regulation of synthetic nicotine products; discussions related to implementation of Public Law 111-31, the Family Smoking Prevention and Tobacco Control Act, and PMTA submissions for deemed tobacco products; H.R. 2125/H.r. 2185/S. 2622, the Quit Because of COVID-19 Act; H.R. 2786/S.1314, the Tobacco Tax Equity Act of 2021; H.R. 3051, the End ENDS Act of 2021; H.R. 3226, the Accurate Reporting of Smoking Variants Act of 2021; H.R. 3407/S.411, the Mothers and Offspring Mortality and Morbidity Awareness Act; H.R. 4629/S. 2445, the Resources to Prevent Youth Vaping Act; H.R. 5546/S. 2974, the PROTECT Act
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Tobacco
Risk-proportionate regulation for electronic nicotine delivery system products to advance tobacco harm reduction for adult smokers and policies to combat underage use. Issues related to enforcement of illicit tobacco products, including importation of counterfeit products, and unregulated nicotine products. Issues related to taxation and user fees for tobacco and electronic nicotine delivery system products. Issues related to regulation of synthetic nicotine products. Discussions related to implementation of Public Law 111-31, the Family Smoking Prevention and Tobacco Control Act, and PMTA submissions for deemed tobacco products. H.R. 2125/H.R. 2185/S. 2622, the Quit Because of COVID-19 Act. H.R. 2786/S. 1314, the Tobacco Tax Equity Act of 2021. H.R. 3051, the End ENDS Act of 2021. H.R. 3226, the Accurate Reporting of Smoking Variants Act of 2021 H.R. 3407/S. 411, the Mothers and Offspring Mortality and Morbidity Awareness Act. H.R. 4629/S. 2445, the Resources To Prevent Youth Vaping Act H.R. 5546/S. 2974, the PROTECT Act H.R. 6286, the Clarifying Authority over Nicotine Act of 2021
Client expense: $580,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Tobacco
Risk-proportionate regulation for electronic nicotine delivery system products to advance tobacco harm reduction for adult smokers and policies to combat underage use. Issues related to enforcement of illicit tobacco products, including importation of counterfeit products, and unregulated nicotine products. Issues related to taxation and user fees for tobacco and electronic nicotine delivery system products. Discussions related to implementation of Public Law 111-31, the Family Smoking Prevention and Tobacco Control Act, and PMTA submissions for deemed tobacco products. H.R. 2125, the Quit Because of COVID-19 Act. H.R. 2786/S. 1314, the Tobacco Tax Equity Act of 2021. H.R. 3051, the End ENDS Act of 2021. H.R. 3226, the Accurate Reporting of Smoking Variants Act of 2021 H.R. 3407/S. 411, the Mothers and Offspring Mortality and Morbidity Awareness Act. H.R. 4629/S. 2445, the Resources To Prevent Youth Vaping Act
Client expense: $590,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Tobacco
Legislation: S. 2599 Senate FY 2022 Appropriations for the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies (Lobbying activities related to FY 2022 appropriations for the Food and Drug Administration and protecting FDAs authority to oversee all tobacco products) H.R. 4356 House FY 2022 Appropriations for the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies (Lobbying activities related to FY 2022 appropriations for the Food and Drug Administration and protecting FDAs authority to oversee all tobacco products) S. _____ Senate FY 2022 Appropriations for the Departments of Labor, Health and Human Services, and Education, and Related Agencies (Lobbying activities related to FY 2022 appropriations for the Centers for Disease Control and Prevention) H.R. 4502 House FY 2022 Appropriations for the Departments of Labor, Health and Human Services, and Education, and Related Agencies (Lobbying activities related to FY 2022 appropriations for the Centers for Disease Control and Prevention) H.R. 2125/S. 2622 Quit Because of COVID-19 Act H.R. 2786/S. 1314 Tobacco Tax Equity Act of 2021 H.R. 3226 Accurate Reporting of Smoking Variants Act H.R. 4629/S. 2445 Resources to Prevent Youth Vaping Act H.R. 5376 Build Back Better Act (re tobacco tax & tobacco cessation) H.R. 5546/S. 2974 Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction (PROTECT) Act H.R. ____ Reversing the Youth Tobacco Epidemic Act Issues: COVID-19 and tobacco E-cigarette marketing FDA action to address menthol cigarettes and flavored cigars FDA regulation of synthetic nicotine FDA regulation of tobacco products FDA review of e-cigarettes Medicaid and tobacco cessation Tobacco and maternal health Tobacco cessation Tobacco taxes Tobacco's role in health disparaties
Client expense: $158,000 · Firm income: Not reported
2021 · second_quarter · Tobacco
Lobbying Report: April 1 - June 30, 2021 Legislation: S. _____ Senate FY 2022 Appropriations for the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies (Lobbying activities related to FY 2022 appropriations for the Food and Drug Administration and protecting FDAs authority to oversee all tobacco products) H.R. 4356 House FY 2022 Appropriations for the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies (Lobbying activities related to FY 2022 appropriations for the Food and Drug Administration and protecting FDAs authority to oversee all tobacco products) S. _____ Senate FY 2022 Appropriations for the Departments of Labor, Health and Human Services, and Education, and Related Agencies (Lobbying activities related to FY 2022 appropriations for the Centers for Disease Control and Prevention) H.R. _____ House FY 2022 Appropriations for the Departments of Labor, Health and Human Services, and Education, and Related Agencies (Lobbying activities related to FY 2022 appropriations for the Centers for Disease Control and Prevention) H.R. 2125/S. ___ Quit Because of COVID-19 Act H.R. 2786/S. 1314 Tobacco Tax Equity Act of 2021 H.R. 3051 Ending Nicotine Dependence from Electronic Nicotine Delivery Systems (END ENDS) Act H.R. 3226 Accurate Reporting of Smoking Variants Act H.R. 3883/S.___ Legislation to prohibit smoking on the premises of any facility of the Veterans Health Administration S. 674 Public Health Infrastructure Saves Lives Act H.R. ___ Reversing the Youth Tobacco Epidemic Act H.R. ___/S. ___ Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction (PROTECT) Act S. ___ ENND Act Issues: 1.) Andrea Palm nomination for Deputy Secretary of HHS 2.) Dawn OConnell nomination for Assistant Secretary for Preparedness and Response at HHS 3.) COVID-19 and tobacco 4.) FDA action to address menthol cigarettes and flavored cigars 5.) FDA regulation of tobacco products in general 6.) FDA review of PMTA applications 7.) Medicaid and tobacco cessation 8.) Prohibiting menthol cigarettes 9.) Synthetic nicotine 10.) Tobacco and maternal health 11.) Tobacco tax in general 12.) Tobaccos role in health disparities Agencies Visited: US House of Representatives US Senate Centers for Disease Control and Prevention Food & Drug Administration
| Democratic |
| CA |
| Lisa Blunt Rochester | Democratic | DE |
| Mark DeSaulnier | Democratic | CA |
| Raja Krishnamoorthi | Democratic | IL |
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Client expense: $141,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE